When alliances fail, is arbitration the answer?
The global pandemic has increased collaboration and a new wave of disputes is likely. Arbitration is well placed to help, argue Kate Davies McGill, Gaela Gehring Flores and Paul Keller of Allen & Overy
- NHS v Servier: unlawful means tort claim fails, but the long-running saga continues 17-08-2021
- A new drug pricing system reform proposal in Japan 17-08-2021
- UK experimental use exemptions: Part 3—the expanded exemption 05-08-2021
- UK experimental use exemptions: Part 2—the Bolar exemption 22-07-2021
- UK experimental use exemptions: part 1—the original 15-07-2021
Latest generics news
BMS says Hengrui’s Abraxane infringes
13-05-2022
A subsidiary of Bristol-Myers Squibb has sued Chinese pharma company Jiangsu Hengrui Pharmaceuticals, alleging that the company’s planned generic of cancer medication Abraxane infringes a patent.
